REGADENOSON
UNII 2XLN4Y044H

Substance Identification & Data

This profile provides standardized clinical and technical data for Regadenoson, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 2XLN4Y044H.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 875148-45-1 and the RxNorm Concept ID (RxCUI) 640062. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

2XLN4Y044H

CAS Registry Number

875148-45-1

RxNorm Concept ID

640062

Detailed Substance Profile

Preferred Name

REGADENOSON

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

2XLN4Y044H

The specific atomic composition represented as a molecular structure string.

InChIKey

C15H18N8O5.H2O

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

CDQVVPUXSPZONN-WPPLYIOHSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C74420

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

44154280

Unique identification number in the NCBI database of chemical substances.

USAN ID

TT-01

Identifier assigned by the United States Adopted Names Council.

Substance Type

Regadenoson

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@H]1(O[C@@H]([C@H]([C@H]1O)O)CO)n2c3nc(-n4cc(cn4)C(=O)NC)nc(c3nc2)N.O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Regadenoson. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.